Stay updated on Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial page.

Latest updates to the Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial page
- Check6 days agoChange DetectedPage version updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe study now lists two locations, including Parkland Health & Hospital System in Dallas, TX; this augments the previously listed single-location site.SummaryDifference0.4%

- Check34 days agoChange DetectedAdded Revision: v3.4.2. Removed the government funding status notice and the previous Revision: v3.4.1 from the page.SummaryDifference0.4%

- Check41 days agoChange DetectedPage now shows a government funding lapse notice with the NIH Clinical Center's operating status. The revision label has been updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check48 days agoChange DetectedAdded a Show glossary option and updated metadata labels such as 'Last Update Submitted that Met QC Criteria' and 'Last Update Posted', along with capitalization tweaks to 'No FEAR Act Data' and a new site revision note 'Revision: v3.4.0'.SummaryDifference0.3%

- Check62 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial page.